Clinical Trial Update: A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on a combination therapy with guselkumab and golimumab for Crohn's disease; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Golimumab (golimumab)
• Guselkumab (guselkumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Crohn's Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING